XENT
Intersect ENT, Inc
XENT
XENT
Delisted
XENT was delisted on the 12th of May, 2022.
122 hedge funds and large institutions have $831M invested in Intersect ENT, Inc in 2021 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 41 increasing their positions, 35 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
2% less funds holding
Funds holding: 124 → 122 (-2)
86% less call options, than puts
Call options by funds: $131K | Put options by funds: $911K
Holders
122
Holding in Top 10
3
Calls
$131K
Puts
$911K
Top Buyers
| 1 | +$36M | |
| 2 | +$25M | |
| 3 | +$16.8M | |
| 4 |
WCMNY
Westchester Capital Management (New York)
Valhalla,
New York
|
+$11.7M |
| 5 |
N
Natixis
Paris,
France
|
+$10M |
Top Sellers
| 1 | -$39.6M | |
| 2 | -$16.1M | |
| 3 | -$15.5M | |
| 4 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$12M |
| 5 |
Two Sigma Advisers
New York
|
-$9.16M |